Existing risk assessment strategies for predicting mortality in PAH may be improved by the addition of GDF-15 as a biomarker.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback